Piramal Pharma Ltd is confident that the company's American facilities can help it navigate volatility in its largest US market following Donald Trump's return as president, according to chairperson Nandini Piramal.
Trump's second innings as US president is likely to spell uncertainty for pharma companies, she told Mint, referring to his plan to impose import tariffs to make American industry stronger. "I do think there will be an increase in volatility, but one of the benefits is that we do have manufacturing based in the states. For the customers that can pay the prices, we can manufacture for them. Overall, the Indian industry has lower prices for worldwide patients, which is a good thing." Nearly two-thirds of Piramal Pharma's revenue comes from the developed markets, of which the US contributes 35%. The company has three US-based facilities: Riverview, Michighan for making high potency active pharmaceutical ingredients (APIs); Sellersville, Pennsylvania, which manufactures oral solids, creams, liquids and ointments; and Lexington, Kentucky for making sterile injectables.
The company also expects to be better placed in the US in the coming years as the Biosecure Act comes into play.
The US House of Representatives passed the law in September, prohibiting American pharma players from doing business with certain Chinese drug companies starting 2032. Since then, all eyes have been on Indian contract development and manufacturing organizations (CDMOs) such as Piramal Pharma, Syngene, and Neuland Labs as businesses will look to shift their supply chains to an alternative base.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Retirement Ready? Here Are Some Essential Tips For Financial Security
57% of urban Indians worry their retirement savings will deplete within a decade
PAN 2.0 must aim to end fraud via impersonation
It's welcome that tax authorities are simplifying processes for holders of permanent account numbers. The tech overhaul should also ensure sufficient checks to minimize PAN-theft fraud
Capturing the vintage romance of Havana
The photographs focus on the resilience of Cubans—of keeping music, dance, and laughter alive in the face of various challenges
A treasure trove of recipes from Jahangir's royal kitchen
Food historian Salma Yusuf Husain has translated a 17th century Persian manuscript with 120 rare recipes
Eye contact at meetings must get the attention it needs
Remote work is here to stay but virtual meeting platforms have not addressed their key point of inferiority
Economic advice for Trump and Powell: First, do no harm
Policy moves should help sustain business dynamism in America
Internal audit: AI will transform it by staying vigilant in real time
Embracing tools of artificial intelligence will enable IA to play a vastly enhanced role in delivering value to organizations
We should fix the business of opinion polling in India
Pollsters need self-regulatory mechanisms that can set standards and ensure transparency
Resolving disputes over public procurement: Let's aim higher
It has been a pivotal year for reforms but India needs more to vie for leadership in dispute resolution
Are multi-asset funds a good option amid the market rally?
MAAFs are structured to invest in a mix of asset classes, offering diversification benefits